Authors: Kandaswamy, R Kamps, M Matas, AJ

Citation: R. Kandaswamy et al., Administration of OKT3 as a two-hour infusion does not attenuate first-dose side effects, TRANSPLANT, 68(5), 1999, pp. 709-710